Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Pleural Effusion, Malignant 1Mesothelioma, Malignant 1Mesothelioma 1

Interventions

Cisplatin 4Carboplatin 2viscum album peptide 1sugemalimab 1rilotumumab 1ganitumab 1endostar protein 1Zoledronic Acid 1Valacyclovir 1Thiostrepton 1Surgical Procedures, Operative 1Paclitaxel 1N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea 1Etoposide 1Darbepoetin alfa 1Cetuximab 1Catheters, Indwelling 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Pleural Effusion, Malignant × Thiostrepton × Clear all
NCT05278975 2024-01-26

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

RS Oncology LLC

Phase 1/2 Unknown
186 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡